In recent studies, we’ve observed that varying dosage levels can significantly impact drug efficacy in patient populations. For instance, an analysis conducted last month suggested that a lower dose of a common antihypertensive led to an unexpected increase in patient adherence. I’m interested in discussing similar findings or methodologies others might have applied in their research. What approaches have you found most effective for analyzing such variations?